By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intersect ENT 

(formerly Sinexus)
1049 Elwell Court
Palo Alto  California  94303  U.S.A.
Phone: 650-641-2100 Fax: n/a


Medical Device

Company News
Intersect ENT Schedules Third Quarter 2016 Earnings Release And Conference Call For November 2, 2016 10/19/2016 11:43:18 AM
Intersect ENT Announces Positive Clinical Results Of Pivotal Study Of RESOLVE In-Office Steroid Releasing Implant 10/17/2016 8:12:33 AM
Intersect ENT Announces American Rhinologic Society Endorsement Of The Use Of Drug Eluting Sinus Implants 9/19/2016 11:25:49 AM
Intersect ENT Announces Positive Coverage Decision By CareFirst BlueChoice Inc. Blueshield To Expand Access To PROPEL Steroid Releasing Implants To More Patients 8/29/2016 8:41:59 AM
Intersect ENT Reports Second Quarter 2016 Results 8/3/2016 11:34:01 AM
Intersect ENT Announces FDA Submission Of NOVA Bioabsorbable Steroid Releasing Implant For Patients With Chronic Sinus Disease 8/1/2016 11:32:21 AM
Intersect ENT Announces Preliminary Q2 Revenue and Business Update 7/18/2016 10:09:54 AM
Intersect ENT Announces Publication Of PROGRESS Study Of Steroid Releasing Implant In Patients With Frontal Sinus Disease 7/12/2016 11:02:21 AM
Intersect ENT To Present At William Blair & Company 36th Annual Growth Stock Conference 6/3/2016 10:34:40 AM
Intersect ENT Announces Completion Of Enrollment In RESOLVE II Clinical Trial Of New In-Office Implant For Recurrent Chronic Sinusitis 6/1/2016 1:56:30 PM